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Red”d e”ddiMLlIic wall tld*nQ5 with &rp”l syrtotic ws” 
tkiikootog has been reported to reprerent nwvioble myocardiom 
in patients with chronic connary artery diwacp. To wss 
whether redlaced regtonal end.diaaolir ~81, thiekoers od absent 
wal tbiikeobtg zsxora\-,y identify nonviable myoardium, 25 
palierds with i&w&z Ie,I ventricular dysfunction (eieetion frac. 
tian et rest Yl d 10%) underweal pwiban emisioo Lomegrapby 
with 0xy~lStrMed water ood ‘“fluomdeoxyglocw to we55 
motabotir oclivity ood spbwcho gotcd oucleor magoe:ic relb 
nsoa imaeine 10 owzsure reotooal etidioslolic wall ltdrkness 
In patients with chronic coronary artery disease and ktl 
ventricular sys,olic Dysfunction, regional myocardial asyo- 
ergy a, rest may result from either nonviable myocardium or 
viable but hypoperfuaed and dysfunctional myocardium 
(1.2). The distinction between these two conditions has 
relevant clinical imdicabons because many aswrric vet 
viable myocardin! &ions fecOver function after c&n&y 
revasculafization (3-5), leading u, an increase in giobal left 
ve&cLdr systolic function (3,4). In recent years, myocar- 
dial met&G imaging with posirrvn emission tomography 
has emerged as an accurate. noninvasive technique for 
distinguishing asynergic viahle from nonviable myocardium 
in patients with coronary artery disease (4-6) and in predict- 
i*tg the recovery of regiona! and global left ventricular 
systolic function after revasculorization (4.5). Nuclear mag- 
netic resonance (NMR) imaging has also been repor;ed (7.8) 
,G iden,Jy nonviable myocardiom in patients wi,h chronic 
coronary artery disease. on the hosis of presence of reduced 
regional wa!l thickness accompanied by lack of regmoal 
systolic i~all thickening. Although NLR imaging provides 
hztter spatial resolution and image definition compared with 
posilmr: emission tomography sod ~I!OWS the evaluation Of 
regional .ystolic function, the accuracy of this apprwh in 
the differentiation belween viabk and nonviabfe myawr- 
dium has never been validated against established rcxkers 
of myocardial viahilly. namely, the presence of metabolic 
activity or recovery of regional function after revasculariza- 
tian. 
Thu,. ihe oumose of the present study was lo determine 
.e ability of regional end-&stolic wall thickness and re- 
cional svstolic wall thickening measuremenis to predict the 
~resenck or absence of region? metabolic aclivity~in patienis 
with chronic coronary xtery disease and leh ventricular 
dysfunction. 
Methods 
Study patients. We studied 25 patienls (23 men and 2 
women) riilh angiographically docunented coronary artery 
disease (defined a~ the presence of SSOW diameter stenosis 
in at least one major epicardial coronary artery) and left 
ventricular global systolic dysfunction. The mean age was 58 
+ 9 years traege 38 to 78) and the mean radionuclide ejection 
fraction at rest was 27 c IO% (range IO% to 47%). Thirteen 
of the 25 patients had triple-xssel and 7 patients had 
double-vessel coronary artery disease. Only one patient 
repotted a history of diabetes mellitus. Fifteen of 25 patients 
reported a history ofprevious myocardial mfarction, and the 
presence of pathologic Q waves oo the elccirocnrdiogram 
(KG) WAS identified in an additional 4 patients. Twelve 
patients reported the occurrence of exertional angina and 
three patients had exertional dyspnea. Nine of the remaining 
IO patients developed ECG signs of &hernia during exer- 
cise. All patients underwent equilibrium radionuchde angi- 
ography at rest and during exercise, positron emission 
tomography at rest after the administration of oxygen-15- 
labeled water (Ha”0) and ‘BRuorodeorygkrcose. and gated 
NMh imaging at rest. In each patient, the positron emission 
tomographic and NMR studies were performed within a 
mean interval of 3 ?z 3 days. All cardiee medications were 
withdrawn for ~48 h in 21 patients. All patients gave 
informed written conwut to the protocol, which was ap- 
proved hy the Institutional Human Research Committee in 
March 1989 tnrotocol #&H-2091. The estimated radiation 
exposure did not exceed 0.78 rad total body dose. 
Radtanurttde angiography. Ga:cd cquitibricm radionu- 
elide angiograpky was perfirmed et rest and during bicycle 
exercise with the patient in the supine position using red 
blood cells labeled in viva with 20 to 25 mCi of technetium- 
99m. Radionuchde &giography was performed a mtan of 
35 f; 5’ days hefore the NMR study and within 37 + 53 days 
of the positrou emission study. High temporal resolution 
(‘20 mslframe) time-activity curves were ~eneratcd, from 
which the left ventricular ejection fraction was computed as 
previously described (9). Cardiac medications were discon- 
tinued for 248 h before the study in 2Q of 25 patients. 
Ejection fraction during exercise did not increase in the 
group as a whole (from 27 i 10% to 26 t 13%) and it 
inrreased significantly (>5% increase) in only 4 of the 25 
patients. 
F’ost!ron e&&n tomography. Positron emission tomo- 
graphic imaging was performed as previously described (IO) 
to assess regional myocardial perfusion with H1”O and 
exogenous glucose utilization with ‘8tluorodeaxygkrcose. 
using a whole body posttron emission tomographic cvre!: 
producmg 21 contrguous tomogrsrz s?ased 5. I mm apart 
with a slice thickness of 13 mm and an in-plane recon- 
Wxted resolution of 6.5 mm. Images were obtained per- 
pendicular to the long axis of the body to cre~re 1 serk. of 
bansaxial tomograms. 
One hour i.efore the ‘nlluorodeoxyglucose study. all 
oatient( received 50 a of oral ztuco~e after an overniaht fast. 
kwo separate hotus iijectionCof t2 to 15 mCi of H,% Were 
administered intravenously I2 min apart, followed 15 min 
later by the administration of 5 mCi of “Ruorodeoxyglucose. 
Data were acquired for 5 min in list mode after each H,“O 
injection and for 60 to 75 min in list mode after the 
‘afluorodcoxwlucose iniection. The data heeinnina at 30 min 
after “Auoro&~aygiue&e injection, corrc~pondkg 10 the 
final 30 to 45 min of data acquisition, were reconstructed to 
create tomographic imrges of regiona! myocardia: Ruorode- 
oxyglocose uptake. To prevent tuoieme;:t artifacts. two seat 
belts were fastened around the patient’s thorax during the 
acquisition of the positron study. 
Nuclear magnetic resonance inaging. Eiectrocardio- 
graphic gated NMR imaging was performed using a 1.5 tesln 
scanner. A 15. to 20.min scan allowed acquisition of four to 
five slices at four to live noncontiguous time points in the 
cardiac cycle from end-diastole to end-systole using spin- 
echo imaging (echo time = 20 ms; repetition time = R wve 
to R wave time. two excitations). Each slice was IO mm 
thick, with a center to center slice distance of 20 mm. 
Immediately after this acquisition, a second acquisition was 
begun, again consisting of four to five slices at four to five 
time points to fill in the gaps between slices. The finnl image 
seqttence therefore consisted of 8 or IO contiguous slices 
(lo-mm thickness, IO-mm center to center intersrice dis- 
tance) at four to five time points in the cardiac cycle from 
end-diastole to end-systolc. Total imaging lime was 30 to 
45 min. Images were acquired perpendicular to the body long 
axis and reconstructed as a series oftransaxial romograms to 
allow a direct comparison with the positron emission tome- 
gmmr. 
The time to end-systole was determined before NMR 
imaging from the left ventricular volume curw obtained 
from the radionuclide ventriculogram acqwed at a similar 
heart rate (69 + I2 beatslmin for the radionuclide angio- 
crauhic studv and 72 z ii bea:s/min for the NMR study; 
mein difference between the studies 8 + 6 beats/mink The 
intersequence delay of the NMR scan (that is. the time 
interval between successive time points) could then he 
adjusted so that the last (fourth or fifth) trme pnint of the 
imaging scan occurred at end-systole as determined from the 
radionuclide angiographic study. 
Dala An&is 
Reaionsl mywadttl alucme uptake. In each patient, five 
to si; trans&ial mid&tric&r tomograms from the 
‘8flunr~di-oxvelucore studv were selected for the analvsis. 
To objectivei~measure regional ‘BRuorodeoxyglucose &iv- 
ity, five myocardial regions of interest representing the 
posterolaterat, anterotuterat, ameroapicat, arueroseptet and 
posteroseptal myocardium were drawn on each ‘8Ruom- 
deoxyglucose tomogrom. Regional ‘8Ruorodeoxyglucose uc- 
tivity corrected for partial volume was then computed within 
each region of interest. In each patient, a “normal” myo- 
cardial region was chosen and ihe “Ruorodeoxyglucose 
activity in all rlher regions was normalized to that of toe 
normal reference region. The normal myocardial region in 
each of the 25 patients was chosen on tie basis of the 
presence of normal blood Row (~0.7 mlig per mio; mean I r 
0.23) (I I-!31 and normal systolic wall thickening at rest 
(4.3 -t 2.3 mm). Regional ‘*Rucrodeoxygluco~e activity 
>5@% of that of the reiercncc mgion was considered as 
evidence of metabolic activity (10,14!. Myocardial regions 
showing ‘siluorodeaxyglucose activity ~50% of that of the 
reference region were interpreied as nonviable myocnrdium. 
Replonal myocardial blood flow. We c.>omuled absolute 
regional myocardial blocd flow from the dvnamic Hz% data 
(15). The myocardial regions of interest prevmusly con- 
structed oo the ‘%ilooroJeony8lucose ,mages for measore- 
ment of renional ‘sfluorodeoxvelucose acfivitY were aoolicd 
to the to&graphic H,‘sO da&Lo derive regional myo&dial 
H,“O time-activitv corvcs. AbqoIUIe reeional mvocardial 
blood flow was ca~colated by fitting Ihe myucard;al H,‘50 
time-activity curve. M(r). IO the formulation specified by 
Herrero et al. (Xi: 
M(t) = (PV) F (LV(t) Y e -=‘P”) + (SO) L”(t). 
where the variables of the fit ore PV (a panial v&me 
cmrection factor), F (flow in ml/8 per mm) and SO (a 
spdlover correction factor, indicaCn8 the fraction of counts 
spilling from the lefl ventricular cavity into Ihe myo- 
cardium); x is the convolution operarioo, which corrects for 
the Fact that the injection was not a perfect bolus. The 
partiticn coe!Iicient p was assumed fixed at 0.92. and the 
arterial inpol function I-V(I) was meilrured directly by using 
the positron emission tomographic data from the left veo- 
Uicular cavity (identdied from the NVR ima.einp, tome- 
grams). Note that by fitting the data to this equ&n. one is 
able to simulraneously solve for all three unknown variables 
{that is, flow, spill&r and pardal voloroe recovery cc&- 
cient). ‘This is similar 10 the method of previous investigators 
(ll.l?,16), except our fitting was weighted with the inverse 
vari mce of the data as determined from the total numbers of 
detected coincidences. dead time and correction for accideo- 
tal coincidences. 
This calculation also yields the recovery coefficient ncc- 
wary 10 correct for partial volume effects. This recovery 
coefficient is valid nol just for the Hz’s0 blood flow data. bol 
also for the ‘sfluarodeoxyglucose data cxtrxted from the 
same regions of interest, and WBF :herefore used to correct 
both data sets. 
Regional mymwdial wll Picktwss. To assess regional 
end-diastolic wall thickness ad absolute wall thickening. 
transaxia! enddiastolic and end-systolic NMR images were 
analyzed by two independent operators unaware of the 
‘%orodeo.xyglucose reauhs. The posirron emission fomo- 
graphic slices were aligned visually wiih the corresponding 
NMR slice by two observers unaware of the resuks with 
lhese Iwo techniques with use of both the tomographic 
positron aUenua!;cn images and Ihe positron emission im- 
slice in which the Ii&r first begins to appear are clearly 
visible and could be matched wilh Ihe correswndine s~ruc- 
WC, I” the NMR tomograms. Because oi the &Terenr 
inteniice d&mce (5.i mm for positron emission tomogm 
phy and 10 mm for NMR imaging), each NhiR tommro 
war matched lo two wntiguous Positron etissioo torn& 
granr. Because of the suboptimal visualization of inferior 
mrocardum m the tramaxial view aild the troublesome 
measur~aems of wall thickening in the hawl and apical 
lomograms. only mid-ventricular NMR tomograms were 
aodlyzed. An average of three NMR Aces and six 
%orodeoxyghcose tomographic planes were analyzed for 
each patlent. 
AF just described. each psitroo emissioo tomo8mphic 
slice had been divided into live regions of interest. By 
appropriate resamp:ing. the positron emission lomogmphic 
and NMR images were made to be of identical size (that IS, 
rhe same number ofmmlpixel). The five regions of interest 
drawn on the positron emission tomogram could then be 
superimposed visuallv on the NMR image (with appropriate 
rmations and traoslalions performed as needed). Because 
each resion of interest encompassed a relatively laree 
amount of myocardial tissue. minor misalignments o&&d 
with this visual technique would not significantly alter the 
results. linickness mrx~rcmcnts were made ~, the center of 
each region ofinceresc by manually identifyinga point on the 
epicardial and eodocardial borders perpendicular to the two 
sufixcs. The length of rhe line segmcrd joining these two 
points was calculated and taken asihe wall ~hi&ness. 
Regional sysrnrir wall thickening was defined as the 
difference between end-systolic wall thickness and end- 
diastolic wall thickness. A total of 355 myocardial regions 
were evaluated, avenging i4 per patient. Myocardial re- 
gions were divid& into &ree groups based on the exterd of 
systolic roll th.ckening (17.18): I) akinetic or dyskinetic, 
showing either absence of systolic wall thiikerdngor systolic 
wall thinning: 2) hypokitefic. showing sysfolii wall thickcn- 
inr ~2 mm: and 3) normal. showine svstolic wall thickenine 
3 mm. 
_ . 
Q~ralharive wall morion analysis by radionuclide ;.tgiog- 
rpby was available in 22 of Z5 patients. Wall motion 
abnormalities at resr were observed in 21 of there 22 
pzienls, whereas impaired regional systolic wall thickening 
by NMR inaging was present in all 22 prdients. Ten pa&is 
manifested abnormal wall motion in the lateral wall on 
mdionuclide angiography, and in 9 of them regional systoiic 
wall thickening by NMR imaging was abnormal in Ihe 
corresponding territory. Similarly, radionuciide apical wall 
motion was abnormal in 20 Patients. 18 of whom also 
maniferled abnormal apical wall thickening. Wnally, radio. 
nuclide sepral wall motion was abnormal in 18 patients and in 
all of :hem abnormal septal wa!l thickening was observed. 
Slalis~ical analysis. Data are expressed as mean value ? 
SD. The two-tailed unpaired Student I te,l was applied for 
Figure 1. ‘8Fluaradeaxyglueoae CFDG, uptake (expressed as a 
percent of normal aclivily) ic r&tion to regional systolic fuimion. 
Although akinetic and dyskinetic my0cardml regws exhibited as a 
group reduced ‘*Ruorodeoxygteeose uptake compared with hypo- 
kinetic and normokinetic myocardial regions. a large overlap was 
observed among the three graups. 
comparisons between groups. A p value < 0.0s was ac- 
cepted as the minimal level of significance. 
Results 
Regional wall thickness and blood Bow tn relation to 
systolic wall thickening. Of the 355 myocardial regions eval- 
uated, 89 showed akinesia or dyskinesia at rest (average 
regional systolic wall thickening - I.2 + I .8 mm): 95 myo- 
cardial regions were hypokinetic at rest (average systolic 
wall thickening I.3 ? 0.5 mm), and in the remaining 171, 
systolic wall thickening was normal (4.2 i- 1.7 mm). Re- 
gional end-dmstolic wall thickness did not differ significantly 
among the three grouts of regions (IO + 4, IO z 3 and IO * 
3 mm, respectively): regionai myocardial blood Row also did 
not differ (0.87 t 0.34.0.84 t 0.34 and 0.9 * 0.34 ml/g per 
min. respectively). Regional “Auorodeoxyglucose uptake 
was significantly Iwer in the group of akinetic and dyskl- 
netic regions compaisd with hypokinetic and normokinetic 
regions, although u large overlap among the three groups of 
regions was observed (Fig. I). Among all myocardial re- 
gions, the xrrelation between regional ‘BRuomdeoxyglu- 
cme zc!ivity and either end-diastolic wall thickness (r = 
0.17: (Fig. 21 or systolic wall thickening (r = 0.32) wus poor. 
In particular. asigni!~ant positive linexcorre!ation between 
regional “Auorodeonyglucose activity and regioral end- 
diastolic wall thickness was found in 6 of the 25 patients and 
a significant positive linear correlation between regional 
‘8Ruomdeoxvducoae activity and regional svstolic wall ,_ 
thickening was observed in 2-of the 25~patients: 
Metabolic actX!y in akinetie and dyektnetic myecardtal 
regions. Of the 89 myocardial regions showing akinesia 
or dyskinesia et rest. 65 (74%) had preserved metabolic 
activity (Fig. I) as defined by the presence of regional 
??uorodeoxyglucose uptake by positron emission tomogm- 
phy. Asynergic myocardial regions showing evidence of 
metabolic activity were present in 24 (%%) of the 25 
patients. Regional systolic wall thickening was similar be- 
tween myocardial regions with and those without metabolic 
activity (-1.1 * 1.7 vs. -1.1 i I.9 mm, respectively: p = 
NS). However, akinctic and dyskinetic regions with PE- 
served metabolic activity showed greater &d-diastolic &I 
thickness III i. 4 vs. 7 2 3 mm: D < 0.001) and treater 
regiowl blood flow (0.90 2 0.34 vs..d.67 + 0.34 ml/g p&in; 
p < 0.05) than did regions without metabolic activity. 
The accuracy of regional end-diastolic wall thickness in 
predicting the pwsence or absence of metabolic activify in 
akineric and dyskinclic myocardial regions was then as- 
sessed for different G &ES of end-diastolic thickness (Fig. 3) 
to determine the best combination of sensitivity and speci- 
ficity. This cutoff value corresponded to an end-diastolic 
wall thickness of 8 mm. The sensitivity of un end-diastolic 
wall thickness <8 mm in predicting the absence of metabolic 
activity in akinetic or dypkinetic myocardial regions was 
74% with a specificity of 79% (Fig. 3). However. although 
this cutoff value also yielded a very high negative predictive 
accuracy (90%). the positive predictive accuracy (that is, the 
abdity of end-diastolic wall thickness 18 mm to predict the 
lack of metabolic activity in akinetic or dyskinetic regions) 
was only 55% (Fig. 3). Metabolic activity was present in I4 
of 31 myocardial regions with en end-diastolic wall thickness 
<8 mm. Positive predictive accuracy did not considerably 
Fiyre3. Senritivity. specificity, pattive predictive accomcy (PPA) 
and negative predictive accwocy INPA; oi different end-diastohc 
vatocs in predicting the absence of metabolic activity in ~syoergx 
myocardiat rqions. For each end-diastolic WI,, tbicknerr value, the 
positive poxiictive accuracy was d&red as the ratio between Ihe 
number of akinetic and dyrtinelic x@nen!s wilhoul melabobc 
aelhity W’oe positives and the number of akioetic segments wth 
(false positive) and without #roe positiveI meiawlic activity. Nep- 
a!ive predictive accoracy was defined as the ratio between tke 
nomber dokkioelic and dyskinslis egments wilh metabolic ac,ivi,y 
ttme negative, and the numb<r of akinetic rcgmentr without <false 
negative) and with (true negative) metabolic activiv. For the best 
combination ot’ sensitivity and specificity (7452 and 1%. respc- 
tively)comrpadingtoaneod-diastolic walith~ckoerr of8 mm. the 
&live w&live accuracy is only 5555. indicating the presence 01 
many asynergic regions wilh evidence of metabolic a livily despite 
reduced wall thickness. Lower end-diastolic cvroB valises did not 
sigoilcandy improve the pxitive predictive accuracy and did not 
resolt in a substantial decrease in sensitivity, 
increase for lower cutoff values of end-diastolic wall thick- 
ness in which the sensitivity dramatically decreased (Fig. 3). 
Moreover, only a pwr correlation was Observed between 
‘8Ruorodeoxyglucose activity and end-diastolic all thick- 
ness in regions with akinesia Or dyskinesia (r = 0.27). An 
example Of an akinetic myocardial region wnh reduced 
end-diastolic wall thickness but evidence of melhbolic activ- 
ity is illustrated in Figure 4. 
Metabolic activity In hypokioetic myoexdial qionr. of 
the 95 myocardial regions showing hyookinesia at rest, 87 
(92%) hod metabolic activity by positron emission tomogra- 
phy iFig. I). Twenty-etght myofardial regions (29%) in !his 
gnwp showed an rod-diastolic wall thickness <8 mm; 2: Of 
these manifested metabolic activity. The percent of regions 
with an end-diastolic wall thickness ~8 mm was not signif- 
icantly dilferent from :hat observed in the group Of akinetic 
ad dyskinenc regtons (Table I). Regional ‘sfluorodeony- 
glucoi,e uptake (corrected for par&d volume effects) did no, 
d,Rer s~gmficrntiy between hypokineric regions with tnd- 
dnslalic wall :hickness ~8 or ~3 mm (Table I). These 
Y&W were a!so similar to those observed in akinetic and 
dyrkinetic myocardml regions with an end-diastolic wall 
tbtckness ~8 mm. 
Metabalir activity ia myourdial qioos with normat sy* 
foiic ,,a,, thickening. 3 the 171 myocardial regions with 
oo:m;! s;stol:c watt thickening, 170 (ICC!%) demonstrated 
metabolic activity by pOsitron emission tomography iFig. 1). 
There were 42 myocardial redons (25%) in this group vith 
an end-diastolic wall thickness <B mm, 4; of wtxh mwi- 
fested the presence of metabolic activity. Again, no signifi- 
cant difference in the magnitude of ‘8Ruorcdeoxyglucose 
uptake was observed between myocardial regions with end- 
diastolic wall thickness ~8 OF ~3 mm in this goup(Table I). 
Regimal asyynergy and viable myoardium. Regional 
myocardlal asynergy at rest may arise from ebher underlying 
nonviable myocardtum or dysfunctional yet viable mycar- 
dium (I.?). As a ccmseq~~ence, th  presence of even severe 
regional contmctiw abnormalities alone does not reliably 
indicate the presence of nonviable myocardium (19). lo 
pittients with chronic coronary artery disease. myocardlal 
metabolic imaging wits ‘8Ruor0de0xggJucosr has repeatedly 
demonstrated the presence of metabolic activity indicating 
viable myocardium in many regions showing severely im- 
paired wotll motion at rest (4.20.21). In addition, an improve- 
men, in regional systolic fonctkz atter rrvasco!tization has 
been demonstrated by positmn emission tom~gwpby in 79% 
to 85% of myocardiktl regions with preserved metabolic 
activity and impaired wall m&a at rest (4.5) including 
many territories with seven hypokinesia or akinzsio at rest 
(4). Thus, in the present study, the presence of metabolic 
actiwty. as defined by regional uptake of ‘etluorodeoxyglo- 
case. was considered as the reference gold standard for 
myocardial viability. 
Metabolic activity was observed in 74% oftbe myomdial 
reeions in which viabilitv was at issue (that is. those exhib- 
it& lack of syslolic &II thickening). These dma indicate 
that the maioritv of these territories have residual viable _ . 
myocardiom and are consistent with previous histopatho- 
loric (19). scintimaohic 122.231 and metabolic t24) studies 
sh&i, ;he p&&e of &able myocardium in &majority 
of asynergic territories. Mean end-diastolic wall thickness in 
akinetic and dyskioetic regions wr similar to that observed 
in hypokinetic and normokinetic regions. This tinding can be 
explained by the fact that the group of akinelic L r?d djski- 
netic regions included areas of viable, presumably hibemat- 
ing myoardium and areas of nonviable myacardium; asyn- 
e& -but viable myocwdium has been reported 119) to 
correspond histopatbologically 10 only mirdmal mwle loss. 
whereas asynergic nonviable myocardium is associated with 
FDG EN- End- 
Diastole Sysrole 
Figure 4. Matched posItlo” emlSEion to‘no- 
WiraphiC Fl”dY Ileft, and ““Clear magnetic reso- 
nance imaging tomograms (middle and righl) 
from a patient wilh 2 dilated leR venrride. 
Although Ihe nuclear magnetic reronar~c im- 
ages demonstrate reduced end-diaslolic wall 
thickness withabscntsystolic wall thickeningin 
the sep,um (SE,, tile positron emission toI”o- 
gram shows lBAuorodeoxyglucosc (FDG, up. 
take (and thus preserved metabolic activity) in 
the wne territory, suggesting the prcscncc of 
asynergic but viable myacardium. AP = apex: 
LW = lateral wall. 
substantial muscle loss. This explanation appears consistent 
with the finding that akinetic and dyskinetic myocardial 
regions manifesting metabolic activity also showed as a 
group greater end-diastolic wall thickness than did regions 
without metabolic activity. 
Prtvious clinical studies (7.8) also indicate that nonviable 
myocardial regions are associated with reduced end-diastolic 
wal! thickness and lack of systolic wall thickening. Accord- 
ingly, we assessed the accuracy of different end-diastolic 
wall thickness values in predicting the prcscnce or absence 
of metabolic activity in the myocardial regions exhibiting 
akin& or dyskinesia. The best combination of sensitivity 
and specilcity for predicting the absence of metabolic activ- 
itv io these reeions 174% and 79%. resocctivelv) was ” _.
achieved with a cutoff value of end-diastolic wali thickness 
of 8 mm (Fig. 3). The observed sensitivity was very similar 
to the 67% sensitivity fo! waii thinning awssed by NMK 
imaging in identifying arws of necrosis reported by Filip- 
chuck et al. (25) in patients with coronary artery disease and 
previous myocardia! infarction. However, the positive pre- 
dictive accuracy was suboptimal despite reasonably good 
sensitivity, specificity and negative predictive accuracy. 
Thus, the probability of abxnt metabolic activity in an 
akinetic or dyskinetic m,wardial region with an end- 
diastolic wall thickness <& mm was only 55% (Fig. 3). 
Finally. in all myocardial regions only a very weak correia- 
tion was observed between the magnitude of ‘efluorodeoxy- 
glucose uptake and end-diastolic wall thicknsss (Fig. 21, 
which was also true when the SUIIC analysis was applied to 
regions with absent wall thickening. These findings clearly 
indicate the presence of viable myocardium in many akinetic 
or dyskinclic myocardial regions despite reduced wall thick- 
ness. The occurrence of viable myocardium in myocardial 
regions with reduced end-diastolic wall thickness was also 
confirmed bv the observation that 25% of the mvocardial 
regions showing normal systolic wall thickening had an 
end-diastolic wall thiclieess ~8 mm (Table 1). Moreover, the 
magnitude of regional glucose uptake (after correction for 
the partial volume effect) was not significantly diEwent 
between myocardial regions with an end-diastolic wall thick- 
ness <8 or ~8 mm, both in myocardial regions with hype. 
kinesia and in those with normal sys!olic wall thickening at 
rest (Table I). 
Limitations. In the present study, regional systolic wail 
rhickaine was measured at a sinele time noint in the cardiac 
cycle. c&espondinp to global lec ventrifular end-systole as 
identified fmm mdianuclide anR.ioRnphy. Tbw. given the 
asynchrony of left ventricular contraction in patients with 
coronary artery disease and impaired left ventricular func- 
tion, it is conceivable that some of the mywardtal regions 
manifesting absence of wall thickening had prematurely 
completed their contraction or, conversely, had not reached 
maximal thickening when global left ventricular end-systole 
occurred. 
To allow a direct comparison with the positron emission 
rumograms, WMR images were acquired in :he tnnsasial 
plane perpendicular is the long axis of the body. Thus, the 
obliquity with rhe true cardiac long axis might introduce 
some overestimation of regional myocardial wall thickness. 
However, the mean regional end-diartohc wall thickness 
values reported “t the present >tudy in the three groups ot 
myocardial regions were similar Lo :hnse reported by other 
investigators !Ej 0::“g short-axis Images. Conversely. ac- 
qidsition of NMR imaging data in the short-x& plane has 
also been reported 127) to be suboptimal for the evaluation of 
regional systolic function in the presence of regional iscb- 
emia. Moreover. because absolute and not relative systobc 
wall thickening values were used in the present study. the 
potential inaccuracy in wall thickness measurements would 
have no elect on the regional wall thickening data. Finnlly. 
although image acquisition in the transanial plane might lad 
to an overestimation of regional wall thickness, this effect 
would only strengthen the conclusion of the high frequent) 
of metabolic activity in myocardial regions we iden:lfied to 
have both reduced wall thickness and reduced wrdl thicken- 
ing. 
As with all other techniques. motion of the left ventricular 
wall in and out of the imaging plane during the cardiac cycle 
was not considered. In addition. in the present study. the left 
ventricle was divided into five anatomic regions of interest. 
Althoueh this procedure may he adequate in :erms of the 
usualiv considered vascular terntori&, it is possible Iha: 
some jnhomogenelty of ‘%omdeoxyglucose or blood Row 
occurred within each region. In general. this would couse 
ourresult~ to be understated. Similarly. it should be remem- 
bered that the thickening measurem& were ohained at 
one sin& representative point within each region. 
In the present study. the presence of metabolic activity 
was arbitrarily defined as a relative “Ruorodcox:glucosc 
activity X0% of normal. In previous investigationr ‘10.14) 
we demonstrated that myacardial regions with a reduction in 
9l”oro&oxygl”c”se uptake >5@% of oOr”lRl correspond to 
severe irreversible thallium defects (IO) and manifest ab- 
sence of wall thickenins (141, suggesting that they reprexnt 
nonviable mgocardium. Using the same cutoff vaiue with 
regional tha!!i”a uptake, other investigators (23.28) demon- 
strated that tit: majority of myocardial regions wtth :SG% af 
“omnl tracer uptake do not show improvemen: in function 
after revascularization, suggesting ihat such a cutotT may be 
employed to distinguish between viable and nonviable myo- 
cardium. In fact, the 50% cutoff used in the present study 
correctly predicted viability in 97% of the hypokinetic and 
nommkinetic regions, which are by definition viable. I” 
contrast, only I of75 myoardial regions with ‘?luorodeoxy- 
glucose uptake <SO% of nomal showed normal wall thick- 
ening. In addition. the choice of different thresholds would 
not alter the conclusions of the study because of the wide 
spxxad distribution of ‘Bfluorcdeoxyglucose activity vdues 
in the akinetic and dyskinelic rnyocardial regions (Kg. II. 
Finally. the functional outcome after revascuttizatian of 
myocardittm with absent systolic thickening bu: with pre- 
served metabolic activity. especially m the presence of 
reduced end-diastolic wall thicktteSS. cmnot be predicted 
from the present study and needs to be evaluated. In 
addition. although asyoergtc myocardnl regions with pre- 
served metabolic activity were observed in all but one 
patient in this study, the mass of asynergic viable myacar- 
dium necessary for a clinically relevant improvement IG 
global vcntr~~~la, funcriaa after revasculxization (and 
hence the number of patients who would potentially beneBt 
from coronary xvascularization) cannot br d&;mined frown 
our data. Moreover, because the study patients had stable 
chxmac coronary artery disease and were in good hemody- 
“amic condttion, it is not known whether these findings can 
be extrapolated to the general population of patiems with 
ischemu left ventricular dysfunction. 
Conclusions. Our results demonstrate that metabolic ac- 
tivity is present in the majority of myocardial regions show- 
ing cevere impairment of systolic function under rest condi- 
tions. Many of these terrilories might therefore exhibit 
improved function after rev~cularizar~on. Atthough xsytxi- 
gic mvocardial regions with absent metabolic activity are 
more .:kelv to he thinner than those with preserved meta- 
bo!ic uclivn~. reduced wall thickness with lack of svstolic 
wall thickening is not always associated with n&viable 
myocardium. Thus. mesures of regio~l left ventricular 
anatomy and function may b? of limited value in distinguish- 
ing nonvIable from asynergic viable myocardium in patients 
iri& ibex;; coronary anery disease and left ventricular 
dysfunction 
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